Detalhe da pesquisa
1.
Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).
BMC Cancer
; 22(1): 725, 2022 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780096
2.
Functionally-instructed modifiers of response to ATR inhibition in experimental glioma.
J Exp Clin Cancer Res
; 43(1): 77, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38475864
3.
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system.
Neurooncol Adv
; 5(1): vdad012, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36915613
4.
Multiparametric Longitudinal Profiling of RCAS-tva-Induced PDGFB-Driven Experimental Glioma.
Brain Sci
; 12(11)2022 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36358353
5.
Experimental glioma with high bHLH expression harbor increased replicative stress and are sensitive toward ATR inhibition.
Neurooncol Adv
; 2(1): vdaa115, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33134924
6.
Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia.
EBioMedicine
; 42: 340-351, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952616